Video

ASCRS Live: Erin Powers shares latest pipeline news from BVI Medical

Erin Powers, Vice President of Global Marketing and Product Strategy for BVI Medical stopped to talk with Ophthalmology Times© at the 2023 ASCRS meeting in San Diego, California to share the latest news from the company.

Erin Powers, Vice President of Global Marketing and Product Strategy for BVI Medical stopped to talk with Ophthalmology Times© at the 2023 ASCRS meeting in San Diego, California to share the latest news from the company.

Video transcript

Editor’s note: Transcript lightly edited for clarity.

Erin Powers:

Hello, everyone. My name is Erin Powers. I'm the vice president of global marketing and product strategy for BVI Medical. I'm so delighted to be at ASCRS in San Diego, beautiful city, my hometown. and I just wanted to update you with a couple of exciting things from BVI. So, oh my goodness, we just got approval for our FINEVISION in Japan. So we're launching that product. We are super excited. We also just closed enrollment for our FINEVISION study in the US, we are very committed to bringing our portfolio globally and really looking at making sure that we provide options to surgeons to better provide options to their patients. So please come by our booth, you can see that we really have surround sound technologies from our consumables...We've got the Beyeonics One partnership that we're working with lenses here in the US. We're really excited to partner more with surgeons here and globally, and really just give you the freedom to choose. So have a fantastic meeting and we look forward to meeting you soon.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.